Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 06/30/16
Due: 06/30/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ASIS for Enbrel in Plaque Psoriasis | NCT02112097 | ASIS Corporation | user2@example.com | None | 2016-01-31 | 2017-06-30 | 2018-06-30 | - | - | 2025-07-14 |
| ASIS for Botox in Chronic Migraine | NCT02074163 | ASIS Corporation | user2@example.com | None | 2016-01-31 | 2017-06-30 | 2018-06-30 | - | - | 2025-07-14 |
| ASIS for GAMMAGARD in Primary Immunodeficiency | NCT02123615 | ASIS Corporation | user2@example.com | None | 2016-01-31 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |